Biotech

Novo Nordisk (NVO) - Q3 FY12/25 Earnings Review

Definitely Some Hair On This One

Initiating Coverage Of Merck & Co (MRK).

More evidence of rotation into healthcare stocks

ADMA Biologics Q2 FY12/25 Earnings Review

Running With The Big Dogs

BioNTech (BNTX): More Than a One Hit Wonder?

Another 90% Club Member

mRNA Strikes Back: Moderna’s Attempt at a Sequel (MRNA Q3 FY12/2025 Earnings Review)

Our Biotech Coverage Expands.

Invivyd - Company Review

$IVVD, A Speculative Play In Monoclonal Antibodies